Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...

Hepatitis B is a liver infection that inflames the organ and impacts its ability to function. It can be either acute (short-term) or chronic (long ... to essentially any age group that hasn ...

The study is enrolling newborn males up to seven months of age at screening who are diagnosed ... and infectious diseases such as chronic hepatitis B where no adequate treatments exist.

Introduction: Infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is a public health problem ...

3 German Centre for Infection Research (Deutsches Zentrum für Infektionsforschung DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany 4 Computational Biology for Individualised Medicine, ...

Dicerna Pharma has enticed another big pharma to partner its RNA interference platform, attracting a $200 million upfront deal with Roche for a drug to treat hepatitis B virus infections.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus ... According to Precision BioSciences, the 3 participants differed with regard to age of ...

Although COVID-19 outcomes were worsened by chronic hepatitis B virus coinfection, COVID-19 vaccination mitigated ... Compared with those with COVID-19 alone (mean [SD] age, 48.4 [19.4] years; women, ...

Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ETCompany ParticipantsConstantin Fest - Head of IREmma Walmsley - CEOLuke Miels ...